Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Now is no time to add pressure on businesses: top executives

    Now is no time to add pressure on businesses: top executives
  2. 2

    CJ CheilJedang to spur overseas growth with new Hungary, US plants

    CJ CheilJedang to spur overseas growth with new Hungary, US plants
  3. 3

    Blackpink's solo journeys: Complementary paths, not competition

    Blackpink's solo journeys: Complementary paths, not competition
  4. 4

    Nationwide rail disruptions feared as union plans strike from Dec. 5

    Nationwide rail disruptions feared as union plans strike from Dec. 5
  5. 5

    Seoul to host winter festival from Dec. 13

    Seoul to host winter festival from Dec. 13
  1. 6

    N. Korea, Russia court softer image: From animal diplomacy to tourism

    N. Korea, Russia court softer image: From animal diplomacy to tourism
  2. 7

    Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid

    Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
  3. 8

    [Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts

    [Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
  4. 9

    Main opposition pushes to ease, not postpone, tax on crypto gains

    Main opposition pushes to ease, not postpone, tax on crypto gains
  5. 10

    Actor Song Joong-ki welcomes second child in Rome

    Actor Song Joong-ki welcomes second child in Rome
지나쌤

Caregen earns patent for peptide as treatment for obesity and diabetes

By 윤정현

Published : Oct. 20, 2016 - 11:27

    • Link copied

[DISCLOSURE] Caregen (214370) reported on Oct. 20 that it has obtained a patent for its new peptide as an effective treatment for obesity and diabetes. 

The peptide causes blood sugar levels to remarkably drop and helps break down fat, which will also have significant potential for addressing diabetes. 

New oral peptide drugs for treating diabetes are currently being evaluated in pre-clinical tests.


By Yun Jeong-hyeon (clareyun@heraldcorp.com)

More from Headlines